Overview

Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301

Status:
Not yet recruiting
Trial end date:
2022-03-30
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the effect of food on the rate and extent of absorption and the overall bioavailability of a single dose of CTx-1301 50 mg trimodal tablets in healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Cingulate Therapeutics
Treatments:
Dexmethylphenidate Hydrochloride